Get short URL
Last month, Russia registered its second coronavirus vaccine, EpiVacCorona, which was developed by the country’s research centre Vector.
More than 15 promising compounds for developing an anti-coronavirus drug have been found by experts at the Russian research centre Vector, Russian public health watchdog Rospotrebnadzor said.
“To date, the antiviral properties of more than 500 candidate therapeutic agents have been evaluated. The work is carried out in several stages, including the study of properties in experiments in vitro (on cell cultures) and in vivo (on laboratory animals). More than 15 compounds have been found that have a pronounced antiviral activity and promising for the creation of drugs against COVID-19,” it said.
DETAILS TO FOLLOW